Document is current
Any future updates will be listed below
-
Authors
Gale, Robert Peter https://orcid.org/0000-0002-9156-1676
Hochhaus, Andreas
- License Information
-
More Information
Article History
Received: 16 August 2023
Revised: 29 August 2023
Accepted: 5 September 2023
First Online: 12 September 2023
Competing interests
: RPG is a consultant to Antengene Biotech LLC, Ascentage Pharma Group and NexImmune Inc.; Medical Director, FFF Enterprises Inc.; A speaker for Janssen Pharma and Hengrui Pharma; Board of Directors: Russian Foundation for Cancer Research Support; and Scientific Advisory Boards, Nanexa AB and StemRad Ltd. AH receives research support from Novartis, BMS, Incyte and Pfizer.
Free to read: This content has been made available to all.
